Trade Summary

5 days ago, Talasaz Amirali, serving as Co-CEO at Guardant Health, Inc. (GH), sold 210,000 shares at $109.89 per share, for a total transaction value of $23,076,690.00. Following this transaction, Talasaz Amirali now holds 1,886,504 shares of GH.

This sale represents a 10.00% decrease in Talasaz Amirali's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, May 20, 2026 and publicly disclosed via SEC Form 4 filing on Friday, May 22, 2026 at 4:57 PM ET, 2 days after the trade was made.

Guardant Health, Inc. operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.